breast cancer
Conditions
Interventions
case series:NA
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Advanced breast cancer patients who meet the diagnostic criteria for breast cancer and receive standardized first-line chemotherapy; 2. Aged 18-75 years; 3. Ubenimex capsules were used within 7 days before and after the start of this chemotherapy; 4. ECOG score <=1 score; 5. Participate in clinical studies voluntarily and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with unknown immunohistochemistry of ER, PgR and HER2; 2. Patients with severe heart, liver and kidney diseases accompanied by severe functional disorders; 3. Pregnant or lactating patients; 4. Patients with mental or cognitive impairment; 5. Patients who are still in other clinical studies within 1 month; 6. Doctors assessed patients with poor compliance or other ineligibility conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival;Quality of life score changes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Improvement of immune function indicators; | — |
Countries
China
Contacts
Public ContactWang Xiaojia
Zhejiang Cancer Hospital
Outcome results
None listed